The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular events in patients with symptomatic peripheral…
- Investigator
- Samir K Shah
- Ages
- 18 Years - N/A
- Sexes
- All